Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia
· Delayed Price · Currency is SAR 105.60
+0.20 (0.19%)
Apr 29, 2026, 1:19 PM AST
Nahdi Medical Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 10,213 | 9,446 | 8,714 | 8,616 | 8,066 | Upgrade
|
| Revenue Growth (YoY) | 8.12% | 8.41% | 1.13% | 6.82% | -6.67% | Upgrade
|
| Cost of Revenue | 6,521 | 6,025 | 5,278 | 5,141 | 4,821 | Upgrade
|
| Gross Profit | 3,692 | 3,421 | 3,436 | 3,475 | 3,245 | Upgrade
|
| Selling, General & Admin | 2,786 | 2,577 | 2,499 | 2,500 | 2,397 | Upgrade
|
| Other Operating Expenses | -19.79 | -27.91 | -23.7 | -24.3 | -58.06 | Upgrade
|
| Operating Expenses | 2,766 | 2,549 | 2,475 | 2,475 | 2,339 | Upgrade
|
| Operating Income | 926.06 | 871.66 | 960.74 | 999.82 | 905.94 | Upgrade
|
| Interest Expense | -88.01 | -73.72 | -50.46 | -50.47 | -78.88 | Upgrade
|
| Interest & Investment Income | 48.76 | 50.8 | 56.82 | 12.13 | 2.96 | Upgrade
|
| Currency Exchange Gain (Loss) | 11.37 | 8.34 | 7.91 | 1.8 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -52.75 | -25.67 | -31.47 | -11.15 | 7.61 | Upgrade
|
| EBT Excluding Unusual Items | 845.42 | 831.41 | 943.53 | 952.13 | 837.63 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.49 | 1.54 | 0.22 | -17.37 | 0.15 | Upgrade
|
| Asset Writedown | - | 1.6 | 0.5 | 3.16 | 19.49 | Upgrade
|
| Pretax Income | 845.91 | 834.54 | 944.25 | 937.93 | 857.27 | Upgrade
|
| Income Tax Expense | 15.17 | 13.82 | 51.63 | 50.11 | 44.74 | Upgrade
|
| Net Income | 830.74 | 820.72 | 892.62 | 887.81 | 812.53 | Upgrade
|
| Net Income to Common | 830.74 | 820.72 | 892.62 | 887.81 | 812.53 | Upgrade
|
| Net Income Growth | 1.22% | -8.05% | 0.54% | 9.26% | -4.31% | Upgrade
|
| Shares Outstanding (Basic) | 130 | 130 | 130 | 130 | 130 | Upgrade
|
| Shares Outstanding (Diluted) | 130 | 130 | 130 | 130 | 130 | Upgrade
|
| EPS (Basic) | 6.39 | 6.31 | 6.87 | 6.83 | 6.25 | Upgrade
|
| EPS (Diluted) | 6.39 | 6.31 | 6.87 | 6.83 | 6.25 | Upgrade
|
| EPS Growth | 1.22% | -8.05% | 0.54% | 9.26% | -4.31% | Upgrade
|
| Free Cash Flow | 746.64 | 1,152 | 962.17 | 1,418 | 1,051 | Upgrade
|
| Free Cash Flow Per Share | 5.74 | 8.86 | 7.40 | 10.90 | 8.09 | Upgrade
|
| Dividend Per Share | 5.600 | 5.500 | 5.500 | 5.310 | - | Upgrade
|
| Dividend Growth | 1.82% | - | 3.58% | - | - | Upgrade
|
| Gross Margin | 36.15% | 36.21% | 39.43% | 40.33% | 40.23% | Upgrade
|
| Operating Margin | 9.07% | 9.23% | 11.03% | 11.60% | 11.23% | Upgrade
|
| Profit Margin | 8.13% | 8.69% | 10.24% | 10.30% | 10.07% | Upgrade
|
| Free Cash Flow Margin | 7.31% | 12.19% | 11.04% | 16.45% | 13.04% | Upgrade
|
| EBITDA | 1,215 | 1,130 | 1,181 | 1,192 | 1,070 | Upgrade
|
| EBITDA Margin | 11.90% | 11.96% | 13.55% | 13.84% | 13.26% | Upgrade
|
| D&A For EBITDA | 289.25 | 258.31 | 219.86 | 192.36 | 164.03 | Upgrade
|
| EBIT | 926.06 | 871.66 | 960.74 | 999.82 | 905.94 | Upgrade
|
| EBIT Margin | 9.07% | 9.23% | 11.03% | 11.60% | 11.23% | Upgrade
|
| Effective Tax Rate | 1.79% | 1.66% | 5.47% | 5.34% | 5.22% | Upgrade
|
| Advertising Expenses | 52.94 | 59.61 | 66.36 | 67.81 | 54.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.